Comet Holding AG (LON:0ROQ)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,499	1,702	1,922	1,366	2,118	1,275
Market Cap Growth	-28.27%	-11.43%	40.69%	-35.50%	66.18%	71.75%
Enterprise Value	1,499	1,713	1,939	1,383	2,123	1,300
Last Close Price	198.11	215.26	248.63	170.87	261.93	151.94
PE Ratio	41.95	54.99	133.98	19.49	38.77	55.66
PS Ratio	3.38	4.34	5.19	2.60	5.09	3.89
PB Ratio	5.30	5.94	6.96	4.59	9.51	7.16
P/TBV Ratio	5.96	6.65	7.94	5.20	11.18	9.00
P/FCF Ratio	49.72	48.72	-	34.67	43.22	34.67
P/OCF Ratio	32.24	38.66	92.63	23.63	37.09	26.99
EV/Sales Ratio	3.33	4.36	5.23	2.63	5.10	3.97
EV/EBITDA Ratio	24.85	37.27	54.75	13.86	27.20	33.16
EV/EBIT Ratio	35.38	50.84	83.27	15.57	31.17	44.42
EV/FCF Ratio	49.73	49.03	-	35.10	43.32	35.35
Debt / Equity Ratio	0.30	0.30	0.32	0.30	0.29	0.38
Debt / EBITDA Ratio	1.44	1.71	2.21	0.84	0.79	1.58
Debt / FCF Ratio	2.84	2.46	-	2.23	1.31	1.84
Asset Turnover	0.98	0.89	0.77	1.13	1.13	0.96
Inventory Turnover	2.65	2.40	2.08	2.93	3.01	2.66
Quick Ratio	1.16	2.00	1.94	1.65	1.61	0.76
Current Ratio	1.90	3.17	3.40	2.69	2.51	1.32
Return on Equity (ROE)	12.82%	11.30%	4.90%	25.76%	27.53%	13.46%
Return on Assets (ROA)	5.79%	4.76%	3.03%	11.91%	11.53%	5.38%
Return on Capital (ROIC)	7.13%	5.87%	3.80%	15.78%	16.14%	7.64%
Return on Capital Employed (ROCE)	13.10%	8.90%	6.30%	23.10%	23.10%	14.20%
Earnings Yield	2.38%	1.82%	0.75%	5.13%	2.58%	1.80%
FCF Yield	2.01%	2.05%	-0.09%	2.88%	2.31%	2.89%
Dividend Yield	0.66%	0.61%	0.38%	1.94%	1.08%	0.71%
Payout Ratio	30.35%	22.13%	186.93%	34.81%	14.97%	28.07%
Buyback Yield / Dilution	0.55%	0.06%	0.01%	-0.04%	-0.03%	-0.04%
Total Shareholder Return	1.06%	0.68%	0.38%	1.90%	1.05%	0.67%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.